WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017066714) ANTI-VSIG1 ANTIBODIES AND DRUG CONJUGATES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/066714    International Application No.:    PCT/US2016/057231
Publication Date: 20.04.2017 International Filing Date: 14.10.2016
IPC:
C07K 16/28 (2006.01), A61K 39/395 (2006.01), A61P 35/00 (2006.01)
Applicants: COMPUGEN LTD. [IL/IL]; 26 Harokmim Street 5885849 Holon (IL).
DRAKE, Andrew, W. [US/US]; (IL)
Inventors: DRAKE, Andrew, W.; (IL).
POW, Andrew; (IL).
HANSEN, Kyle; (IL).
BENITA, Yair; (IL).
COJOCARU, Gad, S.; (IL).
SAMEAH-GREENWALD, Shirley; (IL)
Agent: MACDOUGALL, Christina, A.; (US).
ANTCZAK, Andrew; (US).
MANN, Jeffry, S.; (US).
SILVA, Robin; (US).
TALUKDER, Gargi; (US)
Priority Data:
62/242,908 16.10.2015 US
62/247,414 28.10.2015 US
Title (EN) ANTI-VSIG1 ANTIBODIES AND DRUG CONJUGATES
(FR) CONJUGUÉS D'ANTICORPS ANTI-VSIG1 ET DE MÉDICAMENTS
Abstract: front page image
(EN)The disclosure relates generally to compounds with anti-cancer activity and more specifically to antibodies conjugated with chemotherapeutic drugs or toxins. The disclosure also relates to methods of using antibody-drug conjugate compounds for in vitro, in situ, and in vivo diagnosis or treatment of specific cancers.
(FR)L'invention concerne de manière générale des composés ayant une activité anticancéreuse et plus spécifiquement des anticorps conjugués avec des médicaments chimiothérapeutiques ou des toxines. L'invention concerne également des méthodes d'utilisation de composés de conjugués de médicaments-anticorps pour le diagnostic ou le traitement in vitro, in situ, et in vivo de cancers spécifiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)